Print  |  Email
Laboratory: Clinical Biochemistry  (SENDOUTS)
Test Name:
LIPOPROTEIN (a) - (P) and (S)
Test Code: LPA
Clinical Information:
Alternate Name(s): Lp(a), Lipoprotein Little a
Test Indications: Lipoprotein(a) (Lp(a)) levels are robustly associated with the risk of coronary heart disease; strongly suggesting a causal association between Lp(a) and cardiovascular disease (CVD). The risk increases with increasing Lp(a) levels. Lp(a) concentrations > 100 nmol/L (>50 mg/dL) are associated with an increased risk of myocardial infarction independent of established CVD risk factors including diabetes mellitus, smoking and high blood pressure.
The 2021 Canadian Cardiovascular Society (CCS) Guidelines recommend Lp(a) measurement once in a person’s lifetime as part of initial lipid screening.
Recommendations: 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults 
Can J Cardiol. 2021 Aug;37(8):1129-1150. doi: 10.1016/j.cjca.2021.03.016
Canadian Society of Clinical Chemists Harmonized Clinical Laboratory Lipid Reporting Recommendations on the Basis of the 2021 Canadian Cardiovascular Society Lipid Guidelines 
Can J Cardiol. 2022 Apr 1:S0828-282X(22)00215-X. doi: 10.1016/j.cjca.2022.03.019.
Collection Devices:
Serum; Plasma (Li Heparin or EDTA) are acceptable.
Specimen Required:

Minimum Volume:  0.5 mL   
Specimen Stability:
Frozen:  >6 months at -80°C
Serum: 1.0 mL

Shipping & Storage: Store and ship frozen. 
Referred Out Location: Send specimen to Health Sciences Centre - MS5 for referral to In-Common Labs (ICL).
Ship to:
In-Common Laboratories
57 Gervais Drive
North York, Ontario
M3C 1Z2
Telephone: (416) 422-3000
Test ID: LPA
Testing site: St. Michaels Hospital, Toronto, ON
Reference Values:
Reference Intervals: 0-100 nmol/L
Method of Analysis: Particle-Enhanced Immunoturbidimetry
Within 4 Weeks
See Also:
More Information:
References: Kronenberg F. Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill? Atherosclerosis. 2022 May;349:123-135. doi: 10.1016/j.atherosclerosis.2022.04.008.